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ABSTRACT 
 
Background. Pain associated with the insertion of an intrauterine device (IUD) is a known barrier 
to intrauterine contraception use in the UK. It is good practice for health professionals to discuss 
pain relief and use with women prior to the insertion of an IUD.  
 
Objectives. This study aimed to determine the prevalence of and reasons for and against the use of 
local anaesthesia (LA) for IUD insertion. Methods A survey was undertaken using paper 
questionnaires to determine LA use for IUD insertion by UK health professionals. 
 
Results Overall, approximately one quarter (n=129) of all respondents use LA routinely, one 
quarter hardly ever or never use LA, while the remaining half use it sometimes. Use of LA was 
more prevalent among health professionals who worked in integrated sexual and reproductive 
health and contraception-only services, compared to general practice. UK health professionals who 
hardly ever or never used LA for the insertion of IUDs were more likely to be working in general 
practice. 
 
Conclusions The results of this survey suggest that more UK health professionals need to routinely 
discuss pain relief and offer this to their patients prior to IUD insertion as part of the care pathway 
for patients who choose to use intrauterine contraception.  
 
 
 
 
 
 
Key message points 
Key message points 
▸ It is good practice for health professionals to discuss pain relief and its use with women     
     prior to the insertion of an intrauterine device. 
 
▸ Most UK health professionals do not routinely use local anaesthesia (LA) for the insertion  
    of intrauterine contraception. 
 
▸ UK health professionals should routinely discuss pain relief and always consider use of  
    LA for intrauterine contraception insertion in women during contraceptive consultations. 
 
 
 
 
 
 
 
 
 
  
 
BACKGROUND 
Increasing uptake of long-acting reversible contraception (LARC) is an important component of 
strategies to reduce the rates of unintended pregnancy and abortion in the UK. Intrauterine 
contraception is a LARC method that is more cost effective, has higher user continuation rates and 
offers other benefits to women compared to other LARC methods.1 The procedure for the insertion 
of an intrauterine device (IUD) is associated withpain and/or discomfort in some women, which is a 
known barrier to intrauterine contraception use. Health professionals differ in their opinions on 
women’s perceptions of pain or discomfort, as well as about the use of local anaesthesia (LA) for 
IUD insertions.2 There is also no form or type of analgesic or local anaesthetic licensed for IUD 
insertion that is proven to be of value in reducing IUD insertion pain.3 These factors conceivably 
influence health professionals’ decisions to use currently available LA routinely for IUD insertions. 
There are, however, few available data on the opinions and practice of health professionals in the 
UK as regards this issue.  Consequently, a survey was performed in order to determine first the 
prevalence of routine LA use for IUD insertion by UK health professionals, and second, the reasons 
for and against the use of LA. 
 
 
METHODS 
A questionnaire survey was used to obtain opinions and information about the practice of UK 
health professionals who insert IUDs. The questionnaire was developed following a review of the 
scientific literature, consideration of the UK’s Faculty of Sexual & Reproductive Healthcare 
(FSRH) recommendations4 and interviews with experienced health professionals who currently 
insert IUDs. The questionnaire was validated and piloted in a sample (n=10) of experienced health 
professionals working in a contraceptive service. It was anonymous and self-administered. The 
seven item semi-structured questionnaire was printed on a single sheet, participant information 
being requested on the reverse side. The questionnaire was designed to take about 1 minute to 
complete and posed questions about the use of LA for IUD insertions, the type of LA used, reasons 
for infrequent or non-use of LA, and the experience and current practice of the health professional 
concerned. Participants could select or supply more than one reason for and/or against their use of 
LA for IUD insertions.  
 
The survey was carried out at a Current Choices Conference held in London, UK in November 
2011. This conference is an annual academic event organised by the FSRH. The 2-day conference 
is open to all doctors, nurses and allied health professionals who work or have an interest in sexual 
and reproductive health (SRH). Delegates attended the conference from 
all over the UK, however not all of them performed IUD insertions. 
 
Data analysis 
Questionnaire responses were collected and collated using a Google Docs™ Spreadsheet. Values 
for p were calculated using Fisher Exact tests and contingency tables, with frequency of use of LA 
for IUD insertion as outcomes.  
 
Ethical approval 
This survey of health professionals who insert IUDs was exempt from review by an ethics 
committee. 
 
 
 
RESULTS 
A total of 313 delegates attended the conference, half of whom were extrapolated to be health 
professionals who inserted IUDs from current data held by the FSRH. A total of 129 questionnaires 
were returned, although 19 of these were not fully completed, giving a response rate of 82% 
(129/157). Most respondents were manifestly experienced: 86% had been carrying out IUD 
insertions for over 5 years and 67% had performed up to 50 or more IUD insertions in the previous 
12 months. About half (44%) of the respondents worked mainly in an integrated SRH (both 
genitourinary medicine and contraception) service, while almost equal proportions of respondents 
worked mainly in general practice (29%) or a contraception-only service (24%). Only four 
respondents worked mainly in a hospital setting (Table 1). Seventy-five percent of the respondents 
used LA for IUD insertions (28% always, 47% sometimes), while the remainder did not use or 
hardly ever used LA. The health professionals who always used LA, or only sometimes used LA 
for IUD insertions (n=96), worked mainly in integrated SRH services (48%, n=46), in comparison 
to general practice (25%, n=24), contraception-only services (24%, n=23) or a hospital setting (3%, 
n=3). General practice had the highest proportion (41%, n=32) of health professionals who hardly 
ever used or did not use LA, compared to those working in integrated SRH (31%) or contraception-
only services (25%). Topical gel LA was the commonest type of LA used by UK health 
professionals, irrespective of whether they always used LA for IUD insertions, only used LA 
sometimes or hardly ever used LA for IUD insertions (Table 1).Of the total number (n=87) of 
health professionals who ever used (both always and sometimes) topical 
gel LA for IUD insertions, 60% (n=52) usually used topical gel LA alone while the remainder 
(n=37) used it in conjunction with injectable LA. Seventy-eight of these health professionals 
allowed less than 5 minutes, six allowed 6–10 minutes, while three health professionals allowed 
more than 10 minutes for the topical gel LA to act during the IUD insertion procedure. Seventy-five 
respondents gave their reasons for and against the use of LA for IUD insertions. The commonest 
reasons for not using LA were that IUD insertion 
did not require LA (despite an acceptance by the same respondents that the IUD insertion procedure 
was associated with pain) and that using LA may itself cause pain and prolong the procedure. The 
least common reasons cited for LA use included if the patient was nulliparous, if the patient was 
anxious, and if the patient requested LA (Table 2). 
 
 
DISCUSSION 
This survey found that less than one-third of health professionals always used LA for IUD 
insertions. The main reason given for non-use of LA is the belief that the pain associated with IUD 
insertion does not warrant this form of pain relief. Only a few health professionals cited non-
availability of LA or LA facilities or costs as reasons for not always using LA for IUD insertions.  
 
Health professionals who always used LA for IUD insertion worked mainly in integrated SRH and 
contraception services, whereas health professionals who did not use or rarely used LA were more 
likely to be working in general practice. When health professionals did use LA for IUD insertion, 
this was more likely to be topical gel LA only, which was allowed no more than 5 minutes to take 
effect.  
 
This survey examined the use of LA for IUD insertion by health professionals. It was carried out at 
an FSRH conference in the UK attended by more than 300 delegates. This setting maximised the 
inclusion of as many IUD-inserting health professionals as possible at a single event. The short, 
semi-structured anonymous questionnaire encouraged health professionals to participate and answer 
all the questions. The survey was confidential and completed questionnaires could be returned at 
any time during the 2-day conference.  
 
Due to the ‘opt in’ design of the survey, the exact response rate cannot be calculated. However, 
based on current data that 53% of health professionals registered with the FSRH also hold Letters 
of Competence to insert IUDs, it is reasonable to extrapolate that up to half of the conference’s 
attendees insert IUDs. This would infer that the 129 completed questionnaires reflected a response 
rate of 82% (129/157).  
 
The sample surveyed during the FSRH conference may not be representative of health professionals 
who insert IUDs in the UK or the prevalence of LA use for IUD insertion across the UK’s health 
services. In addition, the FSRH conference was more likely to have been attended by practitioners 
who worked in SRH services rather than other settings. For example, only four of the survey 
participants worked mainly in a hospital service; 29% of respondents worked mainly in general 
practice, whereas up to 60% of health professionals registered with the FSRH are believed to be 
general practitioners (GPs). Nevertheless, current estimates and prescribing data suggest that 
although GPs provide 75% and community clinics (SRH services) provide 25% of contraception 
services to women, LARC provision (including IUD insertions) by community clinics is greater 
than that provided by GPs.1 5 6 These data therefore make the proportion of GP respondents in this 
survey significant.  
 
The prevalence of LA use for IUD insertion by UK health professionals demonstrated by this 
survey is similar to the findings of Tolcher2 who determined LA use, amongst other practices 
surrounding IUD insertions, across a single SRH service. Tolcher’s study found that most health 
professionals used topical gel LA for IUD insertion but only sometimes (72%), in comparison to 
those who always (16.7%) or rarely/never (11%) did.2 However, Tolcher did not determine the 
time period that health professionals allowed for the topical gel LA to take effect.  
 
The fear of pain during the insertion procedure is a known deterrent for women choosing to use an 
IUD. Despite minimal evidence that LA or analgesia are wholly effective in reducing or eliminating 
pain associated with IUD insertion, it remains good practice to discuss, offer and use available LA 
for a procedure that may cause pain or discomfort.4 Pain control should be an objective of all health 
professionals in their routine practice when providing care.  
 
The attitudes and arguments of health professionals against always offering and using LA have 
included 
LA being unnecessary, unwanted by patients, and over-medicalisation of the IUD insertion 
procedure.7 8 These reasons are similar to those mostly cited by health professionals in our survey 
against routine LA use for IUD insertion. There is no evidence for these arguments in the scientific 
literature, and indeed they have been refuted.9–11 In contrast, there are reports that most patients are 
satisfied with the use of LA for IUD insertion, and are happy to undergo a repeat procedure 
involving LA in the future.12 13 Moreover, other health professionals have reported LA use to be 
beneficial for IUD insertion.2 14  
 
Time, training and efficacy were other reasons cited by health professionals for not routinely using 
LA for IUD insertions. It is possible that more health professionals used topical gel LA because 
they were not trained in the use of injectable LA which, unlike topical gel LA, has an almost 
immediate effect after administration. Though the use of topical gel LA was more prevalent in the 
current survey, its application was suboptimal since a contact time of less than 5 minutes was 
frequently allowed for the gel to take effect. For gynaecological procedures such as IUD 
insertion it is advisable to allow 5 minutes for Instillagel® (the only currently available lignocaine 
gel anaesthetic in the UK) to take effect.15–17 Where the use of Instillagel has been found to reduce 
associated pain with gynaecological procedures, including difficult 
IUD insertions and removals, 10–15 minutes are typically allowed for it to take effect.18 Health 
professionals who use topical gel LA should therefore allow a contact time of 5+ minutes in order 
to optimise efficacy for IUD insertion pain. Our findings suggest that there may be a need for health 
professionals to learn techniques for topical gel LA administration in addition to injectable LA 
administration for IUD insertion. 
 
CONCLUSIONS 
This survey suggests that the effective use of currently available LA for IUD insertion is not 
substantial and could be increased amongst UK health professionals. The discussion, offer or 
provision of pain relief during IUD insertion is good practice but is usually at the discretion of the 
health professional performing the IUD insertion procedure or the service where the 
IUD insertion is being done. We recommend educating UK health professionals about LA use and 
acceptance as good practice, the provision of suitable equipment, and minimising the extra costs 
and/or time associated with LA administration to encourage more UK health professionals to 
discuss LA with their patients and use LA for IUD insertions.  
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